Moderna Inc. Stock Rises 10.0%, Outperforms Peers

Dow Jones
07/03

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Moderna Inc. surged 10.0% to $79.76 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 1.1% to 52,900.07 and the NASDAQ Composite Index falling 0.8% to 25,832.67.

This was the stock's fifth consecutive day of gains.

Moderna Inc. hit a new 52-week high, surpassing its previous peak of $73.91, which the company achieved on July 1st.

The stock outperformed some of its peers, as Johnson & Johnson rose 3.6% to $263.04, Pfizer Inc. rose 1.8% to $24.32, and Gilead Sciences Inc. rose 4.21% to $131.27.

Trading volume totaled 13.5 million, compared to the 50-day average of 7.7 million.

Data source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

July 02, 2026 16:33 ET (20:33 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10